Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non‐disease‐specific pathway of functional neurologic improvement

INTRODUCTION: Intranasal deferoxamine (IN DFO) has been shown to decrease memory loss and have beneficial impacts across several models of neurologic disease and injury, including rodent models of Alzheimer's and Parkinson's disease. METHODS: In order to assess the mechanism of DFO, determ...

Descripción completa

Detalles Bibliográficos
Autores principales: Fine, Jared M., Kosyakovsky, Jacob, Baillargeon, Amanda M., Tokarev, Julian V., Cooner, Jacob M., Svitak, Aleta L., Faltesek, Katherine A., Frey, William H., Hanson, Leah R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066355/
https://www.ncbi.nlm.nih.gov/pubmed/31960628
http://dx.doi.org/10.1002/brb3.1536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066355/
https://www.ncbi.nlm.nih.gov/pubmed/31960628
http://dx.doi.org/10.1002/brb3.1536

Ejemplares similares